Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2026-03-03 @ 4:14 AM
Study NCT ID:
NCT00866333
Status:
TERMINATED
Last Update Posted:
2019-10-22
First Post:
2009-03-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2 Multi-Center Study of Entinostat (SNDX-275) in Patient With Relapsed or Refractory Hodgkin's Lymphoma
Sponsor:
Syndax Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SNDX-275-0501
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None